3.1 Respondents’ profile
A total of 201 respondents answered the three surveys: 67 affected by type 1 diabetes, 67 affected by heart failure and 67 affected by obesity. Respondents’ characteristics are presented in Table 1. (Insert Table 1)
Most respondents are treated in hospitals and clinics (59%), half of them (50%) are also treated in a medical office. Only 8% are monitored within a specialized structure and 4% in a medical center. 12% of respondents with type 1 diabetes attend a specialized structure followed by 9% of respondents with obesity and only 4% of respondents with heart failure.
New York Heart Association (NYHA) classes were used to evaluate heart failure patients’ functional ability [13]. 15% of respondents reported no limitation of physical activity (class I NYHA). Almost one in two respondents (47%) reported a slight limitation of physical activity (class II NYHA), 28% reported a marked limitation of physical activity (class III NYHA) and 10% reported severe limitation of physical activity with symptoms present even at rest (class IV NYHA).
Body Mass Index (BMI) was calculated: 36% of obese respondents were obese (30<BMI≤35), 36% were severely obese (35<BMI≤40) and 28% were morbidly obese (BMI>40).
3.2 Respondents’ satisfaction and priorities regarding medical care
Respondents were most satisfied with the reputation of healthcare providers (4.1/5), followed by the quality of infrastructures and services (3.2/5) and access to healthcare providers (3.2/5). On the other hand, respondents were least satisfied with relatives or other patients’ recommendation for the place of care (2.2/5), as well as access to coordinated and multidisciplinary care (2.6/5). Respondents with type 1 diabetes are more satisfied than respondents with obesity or heart failure with the access to innovative drugs and medical devices (3.8/5, 3.1/5 and 1.8/5 respectively) (p<0.01) and with taking the patients’ opinion into account for the choice of treatment (3.9/5, 2.7/5 and 2.3/5 respectively) (p<0.01). Respondents with type 1 diabetes are more satisfied (3.1/5) than respondents with obesity (2.1/5) with the access to coordinated and multidisciplinary care (p<0.05). The quality of infrastructures and services in place of care is more satisfactory for respondents with type 1 diabetes (3.3/5) and heart failure (3.6/5) than for respondents with obesity (2.7/5) (p<0.05). In general, respondents with obesity are dissatisfied with medical care. Indeed, 21% of them underwent surgery and complained about the post-surgery follow-up (1.6/5).
Availability and active listening from healthcare providers was ranked the most important criteria concerning medical care for respondents (3.2/6), followed by the access to innovative drugs and medical devices (3.6/6), access to coordinated and multidisciplinary care (3.8/6), taking the patient’s opinion into account for the choice of treatment (4.0/6) and access to healthcare providers (4.2/6). Taking the patient’s opinion into account is more important for respondents with type 1 diabetes (3.5/6) than for respondents with both obesity and heart failure (4.3/6) (p<0.01). Respondents affected by obesity give more importance to coordinated and multidisciplinary care access (3.5/6) than respondents with type 1 diabetes (4.2/6) (p<0.05). Recommendation of the place of care by relatives or other patients is also more important for obese respondents (5.2/6) than for type 1 diabetes respondents (5.6/6) (p<0.05).
According to the matrix, access to coordinated and multidisciplinary care, availability and active listening from healthcare providers and taking the patient’s opinion into account for the choice of treatment are both the least satisfactory and the most important items regarding medical care (Insert Fig. 1, Supplementary Table 1).
3.3 Respondents’ satisfaction and priorities regarding information and services
The item the respondents were most satisfied with was information and practical advice (3.2/5), followed by websites and mobile applications (2.7/5) and connected medical devices (2.6/5). The least satisfactory services are telemedicine, psychological support and connected devices (1.7/5, 2.1/5 and 2.1/5 respectively). Respondents with type 1 diabetes are more satisfied with connected medical devices (3.6/5) than respondents with heart failure (2.3/5) and obesity (1.8/5) (p<0.01). They are also more satisfied with telemedicine (2.1/5) than respondents with obesity (1.1/5) (p<0.05).
Information and practical advice was ranked the most important criteria for respondents (2.8/6), followed by lifestyle and dietary measures (3.7/6), connected medical devices (3.8/6), and both scientific news and psychological support (4.0/6). Lifestyle and dietary measures are more important for respondents with obesity (2.7/6) than for respondents with heart failure (4.1/6) and type 1 diabetes (4.3/6) (p<0.01). They also consider psychological support as more essential (3.5/6) than the others (p<0.01). Type 1 diabetes respondents give more importance to connected medical devices (2.7/6) than other respondents (p<0.01). Telemedicine is more important for respondents with heart failure (4.3/6) than other respondents (p<0.01).
According to the matrix, connected medical devices, lifestyle and dietary measures, and psychological support are both the least satisfactory and the most important items in terms of information and services (Insert Fig. 2, Supplementary Table 2).
3.4 Respondents’ perception and priorities regarding the impact of the chronic condition on quality of life
The most impacted aspect of respondents’ quality of life due to the condition is daily mood (3.5/5) followed by social and family life (3.4/5) and food choices (3.4/5). The least affected aspects are autonomy (2.2/5) and impact on friends and family (2.8/5). Respondents with heart failure and obesity consider that their autonomy is more impacted by their condition (2.6/5 and 2.5/5 respectively) than respondents with type 1 diabetes (1.7/5) (p<0.01). Respondents with obesity and type 1 diabetes consider that their condition has a greater impact on food choices (3.7/5 and 3.6/5 respectively) than respondents with heart failure (2.9/5) (p<0.01). Respondents with obesity consider that their condition has a greater impact on friends and family (3.1/5) than type 1 diabetes respondents (2.3/5) (p<0.05).
Daily mood was ranked the most important aspect on quality of life for respondents (3.3/6), followed by ability to do physical activities (3.4/6), social and family life (3.6/6), autonomy (3.7/6) and food choices (4.4/6). The most important aspect of quality of life is daily mood for type 1 diabetes respondents (3.0/6) and respondents with obesity (3.1/6). It is autonomy for respondents with heart failure, followed by ability to do physical activities (3.1/6 and 3.3/6 respectively). Respondents with type 1 diabetes and obesity give greater importance to daily mood than respondents with heart failure (3.8/6) (p<0.01). Autonomy is considered as more important by respondents with heart failure than by respondents with type 1 diabetes (4.2/6) (p<0.01).
According to the matrix, daily mood, the ability to do physical activity and social and family life are both the most important aspects of respondent’s quality of life and the ones that they fear their chronic condition will impact the most (Insert Fig. 3, Supplementary Table 3).
The most important and least satisfactory aspects regarding medical care, information and services and the impact of the chronic condition on the quality of life are presented in Supplementary Table 4 for each condition.
3.5 Respondents’ care pathways
32% of respondents reported following a therapeutic patient education (TPE) program; 42% (27/64) of them are very satisfied by their TPE (3.0/5). Respondents with type 1 diabetes are the most involved in TPE programs (42%), followed by obese respondents (28%) and respondents with heart failure (25%). Obese respondents are less satisfied with TPE programs (2.3/5) than respondents with heart failure and type 1 diabetes (3.3/5 and 3.4/5 respectively) (p<0.05).
Respondents reported being very interested in participating in coordinated and multidisciplinary medical care, especially if it can improve the outcome of treatments (8.5/10), reduce out-of-pocket costs (7.7/10), and simplify the organization of medical care (7.5/10) (10 meaning very interested to get involved).
Most respondents (68%) use medical devices: 100% of respondents with type 1 diabetes, 55% of respondents with heart failure and 48% of respondents with obesity (p<0.01). 59% of respondents think that medical devices vastly improve their quality of life. Respondents with type 1 diabetes consider that medical devices help to considerably improve their quality of life (78%) to a larger extent than both obese and heart failure respondents (40%) (p<0.01).
Many respondents are willing to better carry their voice to healthcare authorities: 44% would like to become expert patients and 37% are considering joining a patient organization to be able to debate with healthcare providers and industries. 63% of respondents believe that sharing the discussions they have with healthcare professionals with health authorities would help patients’ opinion to be better taken into account. Almost one in two respondents (47%) also believe that improving access to trainings to become expert patients would allow more consideration of patients’ opinion by health authorities.